Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”

Basel Abdelazeem; Kirellos Said Abbas; James Robert Brašić

doi:10.3390/medicina58060793

Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”

Basel Abdelazeem, Kirellos Said Abbas, James Robert Brašić

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	793
Journal	Medicina (Lithuania)
Volume	58
Issue number	6
DOIs	https://doi.org/10.3390/medicina58060793
State	Published - Jun 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.3390/medicina58060793

Cite this

Abdelazeem, B., Abbas, K. S., & Brašić, J. R. (2022). Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”. Medicina (Lithuania), 58(6), Article 793. https://doi.org/10.3390/medicina58060793

Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”. / Abdelazeem, Basel; Abbas, Kirellos Said; Brašić, James Robert.
In: Medicina (Lithuania), Vol. 58, No. 6, 793, 06.2022.

Research output: Contribution to journal › Letter › peer-review

@article{9a549a7f56f34927a1cada2ad31f4464,

title = "Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”",

author = "Basel Abdelazeem and Abbas, {Kirellos Said} and Bra{\v s}i{\'c}, {James Robert}",

year = "2022",

month = jun,

doi = "10.3390/medicina58060793",

language = "English (US)",

volume = "58",

journal = "Medicina (Lithuania)",

issn = "1010-660X",

publisher = "Kauno Medicinos Universitetas",

number = "6",

}

TY - JOUR

T1 - Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy

T2 - A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”

AU - Abdelazeem, Basel

AU - Abbas, Kirellos Said

AU - Brašić, James Robert

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85132256882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132256882&partnerID=8YFLogxK

U2 - 10.3390/medicina58060793

DO - 10.3390/medicina58060793

M3 - Letter

C2 - 35744055

AN - SCOPUS:85132256882

SN - 1010-660X

VL - 58

JO - Medicina (Lithuania)

JF - Medicina (Lithuania)

IS - 6

M1 - 793

ER -

Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this